http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004037150-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e85fced91b5ba035853f124991c3613e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61G10-026
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61G10-02
filingDate 2002-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f1ad45dae6539cb107f6405b737a3c4
publicationDate 2004-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004037150-A1
titleOfInvention Electronically-operated hyperbaric chamber for the treatment of a diabetic foot
abstract The invention relates to a portable, electronically-operated hyperbaric chamber for the treatment of a diabetic foot, which acts directly on the affected extremity of the diabetic patient. The invention comprises the supply of 100 % pure oxygen at a pressure of 3 atmospheres, which, together with the neurostimulating unit, has curative effects with proven results. The inventive chamber can be used to prevent the amputation of lower extremities from patients suffering from diabetes and, given that the chamber is operated electronically, there is no risk of fire or explosion. More specifically, the invention relates to an electronically-operated hyperbaric chamber for the treatment of a diabetic foot, which is totally different from those currently available on the market owing to the novel design thereof. The invention is primarily characterised in that it supplies 100 % pure oxygen which is pressurised at a working pressure of 3 atmospheres without there being any risk of flames since the chamber is operated electronically and in that it stimulates the nerves and muscles using a neurostimulating unit, concentrating the curative effect of the hyperbaric oxygen on the affected extremity of the diabetic patient. The invention is further characterised in that it is: portable, intended for individual use and much cheaper than those currently available on the market. In this way, the inventive chamber can be used to prevent amputations of lower extremities from diabetic patients while averting the risk of burns owing to the electronic operation thereof.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2217317-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2217317-A1
priorityDate 2002-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2036632-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4003371-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10258
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406055
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394197
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441564

Total number of triples: 21.